Suvretta Capital Management 13F holdings, Q4 2023
Holdings as of December 31, 2023 · filings on SEC EDGAR · latest filing →
Suvretta Capital Management disclosed 87 US equity positions worth $2.2bn in its Q4 2023 13F filing. The largest position was BHVN at 8.9% of the reported book, followed by ARCELLX INC and RPRX. Against the Q3 2023 filing, it opened 5 new positions, added to 20 and reduced 19 among the top 50 holdings.
What did Suvretta Capital Management own in Q4 2023? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2023 |
|---|---|---|---|---|---|---|---|
| 1 | BHVN BIOHAVEN LTD | Healthcare | 8.9% | $195.7m | 4,572,836 | 14% | added |
| 2 | ARCELLX INC | 6.2% | $135.2m | 2,435,974 | -15% | reduced | |
| 3 | RPRX ROYALTY PHARMA PLC | Healthcare | 5.0% | $109.2m | 3,887,702 | -5% | reduced |
| 4 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 4.6% | $101.7m | 2,126,306 | 213% | added |
| 5 | KURA KURA ONCOLOGY INC | Healthcare | 4.6% | $99.9m | 6,946,230 | -5% | reduced |
| 6 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 4.3% | $93.8m | 4,056,847 | 16% | added |
| 7 | INTRA-CELLULAR THERAPIES INC | 3.8% | $83.5m | 1,165,948 | -15% | reduced | |
| 8 | INSM INSMED INC | Healthcare | 3.8% | $83.2m | 2,684,487 | -22% | reduced |
| 9 | META META PLATFORMS INC | Communication Services | 3.6% | $77.9m | 220,183 | -22% | reduced |
| 10 | MSFT MICROSOFT CORP | Technology | 2.8% | $60.9m | 161,924 | -26% | reduced |
| 11 | MARINUS PHARMACEUTICALS INC | 2.7% | $58.1m | 5,346,119 | 3% | added | |
| 12 | AMZN AMAZON COM INC | Consumer Cyclical | 2.6% | $55.9m | 368,089 | -41% | reduced |
| 13 | 89BIO INC | 2.5% | $54.6m | 4,888,434 | 81% | added | |
| 14 | APO APOLLO GLOBAL MGMT INC | Financial Services | 2.3% | $50.4m | 540,820 | 182% | added |
| 15 | AMD ADVANCED MICRO DEVICES INC | Technology | 2.2% | $49.2m | 333,468 | -52% | reduced |
| 16 | GE GENERAL ELECTRIC CO | Industrials | 2.1% | $45.5m | 356,180 | 1% | added |
| 17 | GS GOLDMAN SACHS GROUP INC | Financial Services | 1.9% | $42.6m | 110,310 | – | new |
| 18 | TSM TAIWAN SEMICONDUCTOR MFG LTD | Technology | 1.8% | $40.4m | 388,232 | – | new |
| 19 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 1.8% | $40.1m | 694,101 | 96% | added |
| 20 | 430 TERNS PHARMACEUTICALS INC | 1.7% | $37.9m | 5,837,126 | -3% | reduced | |
| 21 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 1.7% | $37.3m | 5,518,881 | -3% | reduced |
| 22 | LVS LAS VEGAS SANDS CORP | Consumer Cyclical | 1.7% | $36.3m | 738,163 | 15% | added |
| 23 | FERGUSON PLC NEW | 1.6% | $34.0m | 176,090 | – | new | |
| 24 | ORCL ORACLE CORP | Technology | 1.6% | $34.0m | 322,050 | 26% | added |
| 25 | 4XC1 KALVISTA PHARMACEUTICALS INC | 1.5% | $32.9m | 2,684,005 | 11% | added | |
| 26 | MCK MCKESSON CORP | Healthcare | 1.3% | $29.4m | 63,460 | 69% | added |
| 27 | CI THE CIGNA GROUP | Healthcare | 1.3% | $28.8m | 96,300 | 2308% | added |
| 28 | ARQT ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 1.3% | $27.4m | 8,473,101 | 646% | added |
| 29 | VZ VERIZON COMMUNICATIONS INC | Communication Services | 1.2% | $27.0m | 716,850 | – | new |
| 30 | ELV ELEVANCE HEALTH INC | Healthcare | 1.2% | $25.3m | 53,735 | 1685% | added |
| 31 | STRO SUTRO BIOPHARMA INC | Healthcare | 1.1% | $24.8m | 5,778,188 | -2% | reduced |
| 32 | COGT COGENT BIOSCIENCES INC | Healthcare | 1.0% | $21.8m | 3,710,539 | 22% | added |
| 33 | T AT&T INC | Communication Services | 0.9% | $20.5m | 1,220,080 | – | new |
| 34 | ARGX ARGENX SE | Healthcare | 0.9% | $20.4m | 53,700 | 1818% | added |
| 35 | CMG CHIPOTLE MEXICAN GRILL INC | Consumer Cyclical | 0.9% | $19.9m | 8,710 | -57% | reduced |
| 36 | HLT HILTON WORLDWIDE HLDGS INC | Consumer Cyclical | 0.9% | $19.9m | 109,262 | -4% | reduced |
| 37 | RCUS ARCUS BIOSCIENCES INC | Healthcare | 0.8% | $18.3m | 957,304 | 60% | added |
| 38 | MREO MEREO BIOPHARMA GROUP PLC | Healthcare | 0.8% | $17.0m | 7,370,838 | 0% | held |
| 39 | BCYC BICYCLE THERAPEUTICS PLC | Healthcare | 0.8% | $16.5m | 914,476 | -10% | reduced |
| 40 | GPN GLOBAL PMTS INC | Industrials | 0.7% | $14.3m | 112,380 | -60% | reduced |
| 41 | JNJ JOHNSON & JOHNSON | Healthcare | 0.6% | $14.1m | 90,097 | 0% | held |
| 42 | ZURA ZURA BIO LTD | Healthcare | 0.6% | $13.3m | 2,850,000 | 0% | held |
| 43 | INFLARX NV | 0.4% | $9.3m | 5,733,910 | 0% | held | |
| 44 | ELAN ELANCO ANIMAL HEALTH INC | Healthcare | 0.4% | $9.2m | 614,300 | 15% | added |
| 45 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 0.4% | $8.9m | 399,451 | -12% | reduced |
| 46 | SNY SANOFI | 0.4% | $8.5m | 171,001 | 47% | added | |
| 47 | ANAB ANAPTYSBIO INC | Healthcare | 0.3% | $7.6m | 354,872 | -26% | reduced |
| 48 | PROK PROKIDNEY CORP | 0.3% | $6.9m | 3,867,847 | 0% | held | |
| 49 | KEZAR LIFE SCIENCES INC | 0.3% | $6.8m | 7,167,591 | 0% | held | |
| 50 | UNH UNITEDHEALTH GROUP INC | Healthcare | 0.3% | $6.8m | 12,823 | -53% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.